Jeff Gilchrist Profile picture
Sep 10, 2023 40 tweets 10 min read Read on X
#Novavax vs mRNA vaccine

This thread explains how @Novavax is different from the #Moderna and #Pfizer #mRNA #vaccines and describes some of the benefits such as broadened #variant recognition, more durable #immunity, and fewer side effects. 🧵1/ Image of COVID-19 virus, mRNA strand, Novavax vaccine spike nanoparticles and a syringe. Image made from content at : https://www.genomicseducation.hee.nhs.uk/blog/why-mrna-vaccines-arent-gene-therapies/ and https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology
An unrolled one-page web view for this long thread that may be easier to read or share can be found here ( ). 2/
Novavax is a protein based vaccine (similar designs have also been used for many years for tetanus, diphtheria and hepatitis B). Novavax presents the full COVID-19 Spike protein in nanoparticles designed to mimic the structure of the virus itself ( ). 3/ novavax.com/science-techno…
Image showing COVID-19 virus with spike protein and Novavax Spike protein trimer attached to a nanoparticle core to mimic the structure of the virus. Image from: https://novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology
mRNA vaccines on the other hand get your immune cells to produce copies of the full Spike protein as single Spikes on their own which may interact differently with the immune system than Novavax's multi-Spike arrangement around a core. 4/ Image showing COVID-19 spike protein created from mRNA inside an immune dendritic cell, on its own. Image from: https://www.youtube.com/watch?v=8nD6Q9X0SFw
This video shows you how the mRNA Spikes are produced in your body ( ). 5/
Another big difference between Novavax and the mRNA vaccines is that Novavax uses an adjuvant called Matrix-M made from the soapbark tree to enhance the immune response to the vaccine. 6/
This adjuvant induces early activation of innate immune cells at the injection site and in the draining lymph nodes ( ). H/T: @paulseaman31 7/ tandfonline.com/doi/full/10.10…
Diagram showing what happens to the vaccine and adjuvant molecules after being injected into the muscle and after being taken up by antigen presenting cells. Image from: https://www.tandfonline.com/doi/full/10.1080/21645515.2023.2189885
You can read the study to to get much more details about the mechanisms of action with Matrix-M, including interesting facts such as within 24 hours both the Spike antigens and adjuvant are undetectable at the injection site... 8/
...since they have already been processed and transported to the draining lymph nodes by immune cells. I wonder if that is one of the reasons why many people feel much less pain in their arms after injection compared to mRNA shots? 9/
Using Matrix-M translates into an improved magnitude and quality of the antibody response to the Spike protein (antigen) and importantly broadened recognition of locations on the Spike (epitopes). 10/
This improvement was actually seen in the real world with the BA.1 and BA.5 variants and the original Novavax vaccine formula. 11/
Both Pfizer and Moderna released bivalent BA.1/BA.5 vaccines in fall 2022 since the antibodies generated from their original mRNA vaccines could no longer neutralize these newer Omicron variants. 12/
Novavax however did not release a bivalent vaccine because their original vaccine formula with Matrix-M still worked with the BA.1 and BA.5 variants. 13/
The Matrix-M adjuvant elicited antibodies from a broader set of locations on the Spike protein (epitopes) so even when some of the locations mutated with BA.1 and BA.5, the conserved locations could still be recognized by the immune system. ( ). 14/ medrxiv.org/content/10.110…
Graphs showing Immunogenicity of NVX-CoV2373 against ancestral and variant strains of SARS-CoV-2, by dose (n=34). (A) Anti-rS IgG titers by dose for the ancestral (n=34) and BA.1 variant (n=31). Data were not available for the BA.1 variant for 3 of 34 participants. Dotted line represents approximate correlates of protection titers as derived for the ancestral strain.22 (B) Neutralizing (ID50) antibody titers by dose for the ancestral, BA.1, and BA.4/BA.5 variants. Dotted line represents approximate correlates of protection titers as derived for the ancestral strain.22 (C) Antigenic cartogra...
There have also been suggestions to improve mRNA vaccine potency, durability, safety and T-cell response by using adjuvants ( ). 15/nature.com/articles/s4155…
In mice they found the adjuvant in mRNA vaccines increased antibody levels 10x and produced Fc-binding antibodies which showed better control over viral replication and help predict resolution of severed COVID-19 ( ). 16/
Many people have anecdotally discovered and reported that Novavax doses had much lower side effects than when they received an mRNA shot. 17/
Multiple studies have now shown this to be the case as well. One preprint study (supported by Novavax) that compares the reactogenicity (frequency of side effects) of Novavax and mRNA vaccines ( ). H/T: @michaelzlin 18/medrxiv.org/content/10.110…
They found a notable difference in the percentage of reported side effect symptoms with Novavax being lower in each category:
* 30.8% lower muscle pain
* 30.4% lower injection site pain
* 25.7% lower fatigue
* 25.4% lower injection site tenderness
* 24.9% lower malaise

19/ Graph of Percentage of Booster Dose Participants Reporting Local and Systemic Adverse Events. Solicited local and systemic adverse events among participants receiving an mRNA booster (blue) or an NVX-CoV2373 booster (orange) which are plotted. Unadjusted results are based on participant diaries collected over 6 days post-vaccination. Image from: https://www.medrxiv.org/content/10.1101/2023.05.31.23290594v1.full
* 22.4% lower swelling
* 18.3% lower headache
* 17.5% lower joint pain
* 13% lower redness
* 12% lower fever
* 3.5% lower nausea/vomiting

20/
What about people who had mRNA doses previously but want to consider Novavax? There have been several studies now that found mixing the two, getting mRNA and then Novavax actually gave better results than just mRNA on its own. 21/
One study found that getting Novavax as a booster after mRNA "may enhance the persistence and durability of vaccine-mediated immunity compared to mRNA options"... 22/
...with slower decay rate compared to an mRNA booster dose and less side effects than mRNA boosters ( ). H/T: @Daniel_E_Park 23/tandfonline.com/doi/full/10.10…
A randomized controlled trial found that getting a Novavax dose after Pfizer mRNA elicited the highest humoral and peak cellular immune responses ( ). H/T: @michaelzlin 24/journalofinfection.com/article/S0163-…
The mRNA + Novavax combination also had the lowest rate of breakthrough infections and the study also found fewer moderate and severe systemic adverse effects for Novavax than Pfizer mRNA. 25/ Graph of Kaplan–Meier curves for risk of self-reported SARS-CoV-2 infections during follow-up. B: seronegative participants randomised before 29th November 2021; Image from: https://www.journalofinfection.com/article/S0163-4453(23)00330-4/fulltext
Neutralising antibodies against Omicron BA.1 and BA.2 were higher with Novavax after mRNA compared to two mRNA doses. 26/
Now you have more details as to how Novavax is different and some of the nice benefits including for people who had mRNA shots previously. 27/
I'm hoping that the Matrix-M adjuvant will again show its ability to broaden the immune system's ability to choose epitopes so that it might continue to work better for upcoming variants as it did when BA.1 and BA.5 emerged. 28/
FYI, I do not work for Novavax or have any investments or make any money from Novavax selling products. 29/
I am a little confused as to why @Novavax just recently filed their regulatory approval paperwork with Health Canada as many people are waiting for the fall boosters so it would be a shame if they were not available soon like the mRNA fall boosters are expected to be. 30/
While vaccines are important, they should be the last layer of protection to rely on in case all the other layers fail and you get exposed. Vaccines should not be the one and only layer governments all seem to be currently relying on. 31/ Click "Show replies" 👇 to continue.
ASHRAE Standard 241, Control of Infectious Aerosols ( ) was released in July 2023 so this should now be adopted and required in air quality standards for buildings like governments already require clean drinking water standards for these same buildings.32/ashrae.org/technical-reso…
It is important to have good indoor air quality, not just from viruses but also for cognitive function and from other air pollutants (like wildfire smoke) which have been linked to various health problems ( ). 33/
Aerosol and particulate matter (PM) particles can also be filtered and removed from the air using HVAC filters like MERV-13 or better, HEPA filters, build yourself CR-boxes with traditional fans or super quiet versions with PC fans. 34/
You can find guides and useful information on my website ( ). 35/covid.gilchrist.ca
Since you don't have control over the air quality in most public spaces you can also use personal filters (aka masks) with a good seal designed to protect from airborne pathogens like N95 respirators. 36/
To find out how well your mask seals, you can see my thread on fit testing ( ) and some of the test results I got comparing masks ( ). 37/
Some people misunderstand and think filters such as HEPA and mask material work like a sieve or chain link fence which allow smaller objects like flies to pass through. 38/
This thread explains how the laws of physics are used to allow the filtering material to stop such tiny smoke and aerosol particles ( ). 39/
@threadreaderapp please unroll

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Jeff Gilchrist

Jeff Gilchrist Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @jeffgilchrist

May 24
*** Ontario Virus Update | May 24 ***

Hospitalizations due to COVID have increased from 34 to 38 in the last update. Influenza hospitalizations decreased from 57 to 51 and RSV decreased from 33 to 20. 🧵1/

#Ontario #Virus #COVID #RSV #Influenza #Hospital This stacked bar chart displays weekly new hospitalizations in Ontario specifically attributed to COVID-19, Influenza, and RSV. The data tracks the fluctuating volume of patients over time, highlighting seasonal surges and the relative contribution of each respiratory virus to the overall healthcare burden.
Looking at age groups, those age 75+ had the highest rates of hospitalization due to COVID but decreased since last update. Second place is age 65-74 which increased, and third place is age 0-4 which also increased. 2/ This 100% stacked area chart illustrates the weekly proportion of COVID-19 hospital admissions per 100,000 population in Ontario across different age groups. The graph visualizes how the relative distribution of hospitalizations shifts over time among demographics ranging from infants to seniors aged 75 and older.
COVID case rates were fairly stable across age groups this past update except for age 80+ which had a significant decrease but still maintain the highest rates. The 0-4 and 60-79 age groups currently have similar rates. 3/ This multi-line graph tracks the weekly rate of COVID-19 cases per 100,000 population in Ontario, categorized by various age groups from infants to seniors aged 80 and older. The data trends highlight the fluctuations in infection rates across different demographics over the year.
Read 10 tweets
May 10
*** Ontario Variant Update | May 10 ***

In Ontario, the NB.1.8.1.* "Nimbus" variant family shot to 74.7% of sequenced genomes from COVID tests while the XFG.* "Stratus" family dropped to 15.8% and the BA.3.2 "Cicada" family decreased below 10% again.🧵1/
#Ontario #COVID #Variant This multi-line chart tracks the lineage frequency of various COVID-19 variant families in Ontario over time, based on sequenced genome samples. The graph illustrates the changing prevalence of specific variant families, showing how different lineages compete and evolve as the dominant strains within the province.
Ontario released another month of sequencing data by age and we continue to see high ratios of Cicada in children with another 51 BA.3.2.2.* sequences out of 617 new sequences ( ). 2/publichealthontario.ca/-/media/docume…
With 126 Cicada sequences from 1,828 total, we see children still have the highest proportion which decreases after age 5-11 as age increases with significant drops from age 60+. 3/ This bar chart illustrates the percentage of the BA.3.2.* Cicada COVID-19 variant lineage among different age groups in Ontario over a designated time period. The graph visualizes the relative prevalence of the lineage across demographics, highlighting how the variant is distributed from young children to seniors aged 80 and older.
Read 11 tweets
Apr 28
*** Ontario Variant Update | Apr 28 ***

There was some competition for variant dominance during the month of March but the NB.1.8.1.* "Nimbus" family currently holds first place with 49.5% while the XFG.* "Stratus" family sits at 38.1% of sequenced genomes from COVID tests. 🧵1/ This multi-line chart tracks the lineage frequency of various COVID-19 variant families in Ontario over time, based on sequenced genome samples. The graph illustrates the changing prevalence of specific variant families, showing how different lineages compete and evolve as the dominant strains within the province.
The BA.3.2 "Cicada" family has been slowing climbing and now above 10%. 2/
Looking at specific variants, RC.5 Nimbus currently holds first place at 13.4%, SH.1 Nimbus is a close second at 13.3%, RC.6 Nimbus is making a comeback at 11.3%, XFG.1.1.2 Stratus is at 8.2%, RT.2 Cicada at 7.2%, PQ.2.1 Nimbus at 5.2%, and RE.1.2 Cicada at 2.1%. 3/ This multi-line chart tracks the lineage frequency of emerging COVID-19 subvariants in Ontario over time, based on genomic sequencing data. The graph visualizes the shifting percentage of total cases represented by each specific lineage, highlighting the growth and competition of various viral strains.
Read 10 tweets
Apr 13
*** Ontario Virus & Variant Update | Apr 13 ***

Hospitalizations due to COVID have gone down from 153 to 123 in the last update. Influenza hospitalizations decreased from 59 to 47 and RSV decreased from 110 to 85. 🧵1/

#Ontario #Virus #Variant #COVID #RSV #Influenza #Hospital Graph of New hospitalizations in Ontario due to COVID, Influenza or RSV.
Looking at age groups, those age 75+ had the highest rates of hospitalization due to COVID but decreased since last update. Second place is age 0-4 and their levels are currently increasing while age 65-74 has the third highest rate and also decreased since last update. 2/ Graph of New hospitalization rate in Ontario due to COVID by age group (100% Stacked).
The youngest age group 0-4 currently have a hospitalization rate due to COVID that are 17x higher than age 5-17, 17x higher than age 18-49, and 2.8x higher than adults 50-64. 3/
Read 25 tweets
Mar 22
*** Ontario COVID Hospitalization Rates by Age ***

Data is now available for hospital admissions due to COVID by age group going back to Oct 2021. This provides interesting insights into how much children have been impacted with serious infections compared to adults. 🧵1/ Graph of New hospitalization rate in Ontario due to COVID by age group (100% Stacked).
Chart of COVID hospital admissions per 100k population by age group from Oct. 2021 to Aug. 2025 in Ontario, Ottawa, and Toronto.
We have heard from many sources throughout the pandemic that COVID isn't serious in children or they are not impacted as much as adults with some people still claiming this today. 2/
What about today, with lower circulation happening more recently and not the huge waves seen in the past, is anyone even being hospitalized for COVID anymore? The most recent update (week of March 8, 2026) there were 188 people hospitalized in Ontario due to COVID. 3/
Read 20 tweets
Mar 14
*** Ontario Virus & Variant Update | Mar 14 ***

Hospitalizations due to COVID have gone down from 190 to 138 in the last update. Influenza hospitalizations remained stable around 49 and RSV decreased slightly from 194 to 184. 🧵1/

#Ontario #Virus #Variant #COVID #RSV #Influenza Graph of New hospitalizations in Ontario due to COVID, Influenza or RSV.
Looking at age groups, those age 75+ had the highest rates of hospitalization due to COVID but decreased since last update. Second place is age 65-74 and their levels are currently decreasing while age 0-4 has the third highest rate and also decreased since last update. 2/ Graph of New hospitalization rate in Ontario due to COVID by age group (100% Stacked).
The youngest age group 0-4 currently have a hospitalization rate due to COVID that are 11x higher than age 5-17, 5.5x higher than age 18-49, and 2x higher than adults 50-64. 3/
Read 16 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(